Day: June 17, 2024

Additional works in the construction contract in Estonia (tram line connecting Old Harbour and Rail Baltic’s Ülemiste passenger terminal in Tallinn)

On 14 June 2024, AS Merko Ehitus Eesti, part of AS Merko Ehitus group, and KMG Infra OÜ signed an addendum to the design and construction contract with Tallinn Urban Environment and Public Works Department for the additional works of the construction of a tram line connecting the Tallinn Old Harbour with Rail Baltic’s Ülemiste passenger terminal. As a result of additional works and adjustment with the construction price index, the current value of the contract is approximately EUR 43 million, plus value added tax. The scheduled deadline of the works is as before, in February 2025. About the conclusion of the original contract, AS Merko Ehitus published stock exchange announcement on 9 August 2022. Under the agreement, a new tram line will be built on a section of approximately 2.5 kilometres, starting at the intersection of Kivisilla/Gonsiori...

Continue reading

HUTCHMED Highlights Publication of Phase III ESLIM-01 Results in The Lancet Haematology

— Publication shows treatment demonstrated durable response rate of 48.4% vs. 0% with placebo — — Presentations at EHA showcased subgroup analyses demonstrating consistent benefits regardless of prior lines of therapies or prior TPO/TPO-RA1 exposure — — Data supported regulatory submission in China accepted in January 2024 — HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 17, 2024 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that results from ESLIM-01, HUTCHMED’s Phase III trial of sovleplenib (HMPL-523), in adult patients with primary immune thrombocytopenia (“ITP”) in China, were published in The Lancet Haematology. Additional details and subgroup results of the study were also presented on June 14 at the European Hematology Association (“EHA”) 2024 Hybrid Congress as...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.